Authors: PIERGA JY CAMPANA F LAGUERRE B PALANGIE T FOURQUET A ASSELAIN B DIERAS V BEUZEBOC P DORVAL T SCHOLL S POUILLART P

Citation: Jy. Pierga et al., TIMING OF COMBINED CHEMORADIOTHERAPY IN THE CONSERVATIVE TREATMENT OFLOCALLY ADVANCED BREAST-CANCER (LABC), European journal of cancer, 34, 1998, pp. 42-42

Authors: PIVOT X RAYMOND E GEDOUIN D DEGARDIN W ARMAND JP LAGUERRE B LEFEBVRE JL RIPOCHE V KAYITALIRE L SCHNEIDER M

Citation: X. Pivot et al., PHASE-II TRIAL OF MTA (LY231514) IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Annals of oncology, 9, 1998, pp. 366-366

Authors: KERBRAT P LAGUERRE B LEFEUVRE C

Citation: P. Kerbrat et al., COMMENTS ON ASCO RECOMMENDATIONS FOR POST TREATMENT FOLLOW-UP OF BREAST-CANCER PATIENTS, Bulletin du cancer, 84(10), 1997, pp. 991-992

Authors: LEBELBINAY S LAGUERRE B QUINTINCOLONNA F CONJEAUD H MAGAZIN M MILOUX B PECCEU F CAPUT D FERRARA P FRADELIZI D

Citation: S. Lebelbinay et al., EXPERIMENTAL GENE-THERAPY OF CANCER USING TUMOR-CELLS ENGINEERED TO SECRETE INTERLEUKIN-13, European Journal of Immunology, 25(8), 1995, pp. 2340-2348